5001252025-04-012025-06-305001252025-06-305001252025-04-012025-06-30in-capmkt:OtherExpenses1Member5001252025-04-012025-06-30in-capmkt:OtherExpenses2Member5001252025-04-012025-06-30in-capmkt:ReportableSegments1Member5001252025-04-012025-06-30in-capmkt:ReportableSegments2Member5001252025-04-012025-06-30in-capmkt:ReportableSegments1Member5001252025-04-012025-06-30in-capmkt:ReportableSegments2Member5001252025-04-012025-06-30in-capmkt:ReportableSegments1Member5001252025-06-30in-capmkt:ReportableSegments1Member5001252025-04-012025-06-30in-capmkt:ReportableSegments2Member5001252025-06-30in-capmkt:ReportableSegments2Member5001252025-04-012025-06-30in-capmkt:ReportableSegments1Member5001252025-06-30in-capmkt:ReportableSegments1Member5001252025-04-012025-06-30in-capmkt:ReportableSegments2Member5001252025-06-30in-capmkt:ReportableSegments2Member5001252025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500125GILLETTENOTLISTEDINE179A01014Gillette India LimitedMain BoardEquity2025-04-012026-03-312025-07-312025-06-27INRLakhsQuarterlyFirst quarterMulti segment2025-07-3112:19:002025-07-3112:42:00Not applicablefalsefalseNo default. 2025-04-012025-06-30UnauditedStandalone70672000006680000071340000001769700000815700000-4250000004889000001040000020460000023154000005179700000195430000001954300000516400000-190000004974000000145690000000001456900000-1170000014452000003259000001044.7144.710044.7144.71The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on July 31, 2025 and have been subjected to a limited review by the Statutory Auditors of the Company.These financial results are prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <BR> The Unaudited Financial Results are prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 “Interim Financial Reporting” (Ind AS-34), as prescribed under Section 133 of the Companies Act, 2013, read with relevant Rules issued thereunder and other accounting principles generally accepted in India. <BR> The Board of Directors of the Company, on January 23, 2025, approved the change of the Financial Year end from June 30th to March 31st. Accordingly, the previous Financial Year of the Company viz., 2024-25 was for a period of nine months commencing on July 1, 2024, and ending on March 31, 2025. <BR> The Company does not have a subsidiary, an associate or a joint venture as at June 30, 2025. <BR> The figures for the preceeding three months ended March 31, 2025, are the balancing figures between the audited figures in respect of the nine months period ended March 31, 2025 and the published unaudited year to date figures upto the second quarter ended December 31, 2024. <BR> The figures for the corresponding three months ended 30th June, 2024 are the balancing figures between the audited figures in respect of the full financial year ended 30th June, 2024 and the year to date figures upto the third quarter of that financial year.Advertisement and sales promotion expense1363700000Other Expenses951700000Grooming5769300000Oral Care129790000070672000007067200000Grooming1535300000Oral Care368100000190340000010400000-613000001954300000Grooming10707300000Oral Care116030000011867600000938750000021255100000Grooming6278600000Oral Care1235100000751370000020524000009566100000Re-measurement of defined benefit plans-15600000-15600000-39000000-11700000